CARDIOVASCULAR AND THROMBOEMBOLIC RISKS AND SECONDARY PREVENTION IN TRANSGENDER PATIENTS

Friday, October 27, 2023

14:00 – 15:00 EST

Location: Palais, 514ABC

Co-Chair(s)

Anthony Sandre (he/him/his)

Clinical Scholar and Vascular Medicine Fellow
McMaster University
McMaster University
Stan Van Uum, MD, PhD, FRCPC (he/him/his)

President
Canadian Society of Endocrinology and Metabolism
Schulich School of Medicine and Dentistry, Western University, London, Ontario

Disclosure(s):

Anthony Sandre: No financial relationships to disclose

Stan Van Uum, MD, PhD, FRCPC: Ipsen: Consultant/Advisory Board (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); Ricordati: Consultant/Advisory Board (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

review management of cardiovascular and thromboembolic risks in transgender care;
describe barriers to adequate vascular care for transgender individuals; and
identify gaps in knowledge pertaining to optimal vascular care in relation to hormonal treatment for transgender individuals.

Session Description: More details to follow.

Presentations:

14:00 – 14:20 EST

ASSESSING AND MANAGING CARDIOVASCULAR AND THROMBOEMBOLIC RISKS IN TRANSGENDER CARE
Presenter: Jean Connors
14:20 – 14:40 EST

IDENTIFYING AND ADDRESSING BARRIERS TO APPROPRIATE CARE FOR TRANSGENDER PATIENTS
Presenter: Carys Massarella (she/her/hers) – Quest Community Health Centre
14:40 – 15:00 EST

PANEL DISCUSSION AND Q&A